tiprankstipranks
Advertisement
Advertisement
Evogene Deepens AI-Driven Transformation as Second-Quarter Loss Narrows and ChemPass Platform Expands
PremiumCompany AnnouncementsEvogene Deepens AI-Driven Transformation as Second-Quarter Loss Narrows and ChemPass Platform Expands
17d ago
EVGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
Premium
Pre-Earnings
EVGN Earnings Report this Week: Is It a Buy, Ahead of Earnings?
20d ago
Evogene Sets Sept. 4 AGM Amid Board Contest and VP Departure
Premium
Company Announcements
Evogene Sets Sept. 4 AGM Amid Board Contest and VP Departure
1M ago
Evogene Showcases AI-Driven ChemPass Platform and Expanded Google Cloud Collaboration in New Investor Deck
PremiumCompany AnnouncementsEvogene Showcases AI-Driven ChemPass Platform and Expanded Google Cloud Collaboration in New Investor Deck
3M ago
Evogene Sets Up $2.9 Million At-the-Market Share Offering With A.G.P.
Premium
Company Announcements
Evogene Sets Up $2.9 Million At-the-Market Share Offering With A.G.P.
3M ago
Evogene says Phase 1 clinical study of BMC128 met primary endpoint
Premium
The Fly
Evogene says Phase 1 clinical study of BMC128 met primary endpoint
3M ago
Evogene’s Ag Plenus, Bayer End Herbicide Collaboration as APTH1 Target Falls Short
PremiumCompany AnnouncementsEvogene’s Ag Plenus, Bayer End Herbicide Collaboration as APTH1 Target Falls Short
4M ago
Evogene price target raised to $2.25 from $1.75 at Alliance Global
Premium
The Fly
Evogene price target raised to $2.25 from $1.75 at Alliance Global
5M ago
Evogene Faces Nasdaq Minimum Bid Price Deficiency, Granted Cure Period to September 2026
Premium
Company Announcements
Evogene Faces Nasdaq Minimum Bid Price Deficiency, Granted Cure Period to September 2026
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100